HER2 genomic amplification in circulating tumor DNA from patients with cetuximab-resistant colorectal cancer
HER2 genomic amplification in circulating tumor DNA from patients with cetuximab-resistant colorectal cancer is a paper indexed in ScholarIQ from OpenAlex.
How many citations does HER2 genomic amplification in circulating tumor DNA from patients with cetuximab-resistant colorectal cancer have?
HER2 genomic amplification in circulating tumor DNA from patients with cetuximab-resistant colorectal cancer has 70 citations in the OpenAlex counts ScholarIQ stores.
When was HER2 genomic amplification in circulating tumor DNA from patients with cetuximab-resistant colorectal cancer published?
HER2 genomic amplification in circulating tumor DNA from patients with cetuximab-resistant colorectal cancer has 2015 year in the ScholarIQ index.
What is the open-access status of HER2 genomic amplification in circulating tumor DNA from patients with cetuximab-resistant colorectal cancer?
HER2 genomic amplification in circulating tumor DNA from patients with cetuximab-resistant colorectal cancer has diamond oa status in the ScholarIQ index.
What is the DOI of HER2 genomic amplification in circulating tumor DNA from patients with cetuximab-resistant colorectal cancer?
The DOI for HER2 genomic amplification in circulating tumor DNA from patients with cetuximab-resistant colorectal cancer is on the source record.
What is the PMID of HER2 genomic amplification in circulating tumor DNA from patients with cetuximab-resistant colorectal cancer?
The PMID for HER2 genomic amplification in circulating tumor DNA from patients with cetuximab-resistant colorectal cancer is on the source record.
What is the OpenAlex record for HER2 genomic amplification in circulating tumor DNA from patients with cetuximab-resistant colorectal cancer?
The OpenAlex for HER2 genomic amplification in circulating tumor DNA from patients with cetuximab-resistant colorectal cancer is on the source record.